0001209191-23-014892.txt : 20230302 0001209191-23-014892.hdr.sgml : 20230302 20230302180206 ACCESSION NUMBER: 0001209191-23-014892 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230302 DATE AS OF CHANGE: 20230302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Markel Stacy CENTRAL INDEX KEY: 0001734780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39351 FILM NUMBER: 23700729 MAIL ADDRESS: STREET 1: RIGEL PHARMACEUTICALS, INC. STREET 2: 1180 VETERANS BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvation Bio Inc. CENTRAL INDEX KEY: 0001811063 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850862255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 754-3517 MAIL ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: Panacea Acquisition Corp DATE OF NAME CHANGE: 20200430 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-28 0 0001811063 Nuvation Bio Inc. NUVB 0001734780 Markel Stacy C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036 0 1 0 0 Chief People Officer Class A Common Stock 4591 D Stock Option (Right to Buy) 1.94 2023-02-28 4 A 0 500000 0.00 A 2033-02-27 Class A Common Stock 500000 500000 D Includes 3,000 shares acquired on May 19, 2022 and 70 shares acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan. Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date Stacy Markel, by /s/ Ron A. Metzger, Attorney-in-Fact 2023-03-02